Search details
1.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Article
in English
| MEDLINE | ID: mdl-34597472
2.
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
BJU Int
; 128(5): 607-614, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33909949
3.
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int
; 128(2): 196-205, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33556233
4.
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Cancer
; 126(6): 1208-1216, 2020 03 15.
Article
in English
| MEDLINE | ID: mdl-31829450
5.
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
J Urol
; 204(1): 63-70, 2020 07.
Article
in English
| MEDLINE | ID: mdl-31971495
6.
HLA-A*03 and response to immune checkpoint blockade in patients with cancer.
Lancet Oncol
; 23(3): e99, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35240100
7.
Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies.
Biology (Basel)
; 12(8)2023 Jul 30.
Article
in English
| MEDLINE | ID: mdl-37626955
8.
Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinoma.
Urol Oncol
; 41(6): 296.e17-296.e28, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36931981
9.
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 21(2): 286-294, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36481176
10.
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy.
Clin Genitourin Cancer
; 21(4): 507.e1-507.e14, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37150667
11.
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Clin Genitourin Cancer
; 21(5): 584-593, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37414620
12.
Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes.
Clin Genitourin Cancer
; 20(2): 139-147, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35101380
13.
ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution.
Hum Pathol
; 130: 65-78, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36252860
14.
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(6): 558-567, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36155169
15.
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer
; 20(2): 165-175, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35078711
16.
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(5): e440-e452, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35778337
17.
Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
Urol Oncol
; 39(8): 496.e1-496.e8, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33551249
18.
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program.
Clin Genitourin Cancer
; 19(2): 144-154, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33160889
19.
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Eur Urol Oncol
; 4(3): 464-472, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33423945
20.
Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature.
Clin Genitourin Cancer
; 18(3): e266-e276, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32178979